Memantine Eg (Memantine Hydrochloride)

Memantine works by binding to the phencyclidine site of NMDA‑type glutamate receptors, acting as a non‑competitive antagonist. This blocks excessive calcium entry caused by over‑activation of glutamate, reducing excitotoxic neuronal damage while allowing normal synaptic transmission to continue.

The appropriate dose of Memantine EG is determined by the prescribing clinician based on the patient’s clinical condition, renal function and other individual factors. No fixed dosing regimen is provided here; the prescriber will set the exact regimen.

Safety data for memantine during pregnancy and lactation are limited. The drug is classified as having an unknown risk, so clinicians should evaluate the potential benefits against possible risks before prescribing to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

The primary alternative for Alzheimer’s disease is the acetylcholinesterase‑inhibitor class (e.g., donepezil). While acetylcholinesterase inhibitors increase cholinergic activity, memantine modulates glutamatergic excitotoxicity. Both may be used alone or together, but they target different neurochemical pathways and have distinct side‑effect profiles.

Memantine EG should be stored at ambient temperature, below 25 °C, in its original container. Keep the product away from moisture, direct sunlight and heat sources to maintain stability and potency.

Memantine EG is taken orally, usually with water. It can be administered with or without food, according to the prescriber’s instructions. Swallow the tablet whole; do not crush or chew unless specifically advised.

Serious risks include the possibility of seizures, severe skin reactions such as Stevens‑Johnson syndrome, significant hepatic injury, cardiac arrhythmias and emergent suicidal thoughts. Patients should be monitored closely for any of these events and seek immediate medical attention if they occur.

Memantine EG should be avoided in patients with known hypersensitivity to memantine or any excipients, in those with severe renal impairment where dose adjustment is not feasible, and in individuals experiencing uncontrolled seizures. Clinicians should also exercise caution in patients with unstable cardiac conditions.